Study of Oxaliplatin and Xeloda and Cetuximab as First Line Treatment for Metastatic or Unresectable Gastric or Gastroesophageal Junction Cancer
NCT00183898
Digestive System Diseases, Digestive System Neoplasms
Los Angeles, California, United States
View Trial Details